Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004075034 | SCV003532478 | uncertain significance | not specified | 2021-08-16 | criteria provided, single submitter | clinical testing | The c.2032T>C (p.F678L) alteration is located in exon 18 (coding exon 18) of the LGR5 gene. This alteration results from a T to C substitution at nucleotide position 2032, causing the phenylalanine (F) at amino acid position 678 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |